Delivery Order SPE2DB24D8001-SPE2DB25FKZDW
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,489.36, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a prescription medication. The contract, valued at $1,863.70, has an ultimate completion date of August 29, 2024. Dakota Drug, Inc. is an experienced prime contractor to the DLA Troop Support Medical, providing a wide range of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKYUT, was granted by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,602.12, is for the delivery of the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. This award is not associated with a set-aside program and is a firm fixed price, delivery order contract type. Dakota Drug, Inc. has a significant Indefinite...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPWS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a ceiling value of $3,267.50. The contract has an ultimate completion date of October 16, 2023 and was awarded on October 13, 2023. This award is not associated with a set-aside program,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQCG, was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a ceiling value of $7,645.48 and a completion date of December 1, 2023. Dakota Drug, Inc. is a critical supplier of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYVL, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The $3,690.23 firm fixed-price delivery order is not set aside. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,972.28 to Dakota Drug, Inc., a small disadvantaged business, to provide Actemra ActPen 162 mg/0.9 ml injectable medication. This contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $6,286.96, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a performance period through January 6, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a $2,732.81 firm fixed-price delivery order award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The award is for the delivery of Actemra Actpen 162 mg/0.9 ml medication. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which enables the company to provide a wide range of pharmaceutical products,...
The federal contract award with ID SPE2DX15D8001|SPE2DX24FBQRY was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. This $1,584.03 firm fixed-price delivery order contract provides for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a rheumatoid arthritis biologic medication. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, and has over two decades of experience...